Why In News?

The Indian Council of Medical Research (ICMR) confirmed no novel H1N1 mutations in current swine flu cases, noting existing vaccines and antivirals remain effective.

About H1N1 Influenza

Viral Classification & Family: H1N1 is an acute respiratory pathogen belonging to the Influenza A genus within the Orthomyxoviridae family, containing a segmented, single-stranded negative-sense RNA genome.

The Dual Glycoprotein Spikes (H & N):

  • Hemagglutinin (H1): A surface protein that binds to sialic acid receptors on human respiratory epithelial cells, facilitating viral attachment and cell entry.

  • Neuraminidase (N1): An essential enzymatic spike that cleaves sialic acid residues, allowing newly assembled virions to bud off and infect adjacent lung cells.

Modes of Transmission: Spreads rapidly via airborne respiratory droplets expelled during coughing or sneezing, aerosol suspension in unventilated indoor spaces, and indirect contact with contaminated fomites (door handles, desks).

Incubation Period & Clinical Symptoms: Has a short incubation period of 1 to 4 days (average 2 days); presents with sudden high fever, persistent dry cough, sore throat, severe myalgia, headaches, fatigue, and nasal congestion.

High-Risk: While healthy adults experience self-limiting illness resolving in 5 to 7 days, severe complications (viral pneumonia, acute respiratory distress syndrome - ARDS) occur in unvaccinated elderly (65+), children under 5, pregnant women, and individuals with co-morbidities (diabetes, asthma, chronic kidney disease).

Antigenic Drift versus Antigenic Shift:

  • Antigenic Drift: Continuous minor point mutations during viral RNA replication that alter surface proteins gradually, producing seasonal flu variants that require annual vaccine updates.

  • Antigenic Shift: Sudden, major genetic reassortment between distinct human, swine, and avian flu strains in an intermediate animal host, creating an entirely novel subtype that bypasses population immunity and causes global pandemics (as seen in the 2009 H1N1 pandemic).

  • Diagnostic Gold Standard: Confirmed via Reverse Transcription-Polymerase Chain Reaction (RT-PCR) from nasopharyngeal and oropharyngeal swabs within 48 to 72 hours of symptom onset.

Treatment: Treated with oral Oseltamivir or inhaled Zanamivir, which inhibits the neuraminidase enzyme to halt viral replication across respiratory tissues.

Preventive Immunization: Annual seasonal influenza vaccination—available in trivalent (H1N1, H3N2, B/Victoria) and quadrivalent formulations—confers robust protective neutralizing antibodies.

Source: PIB

PRACTICE QUESTION

Q. With reference to the structure and epidemiology of the H1N1 Influenza virus, consider the following statements:

1. Hemagglutinin facilitates viral entry into host cells, while Neuraminidase enables the release of newly formed viral particles.

2. Antigenic drift involves major genetic reassortment between human and animal flu strains capable of causing global pandemics.

3. Oseltamivir is an antiviral medication that acts as a neuraminidase inhibitor.

Which of the statements given above are correct?

(a) 1 and 2 only

(b) 1 and 3 only

(c) 2 and 3 only

(d) 1, 2, and 3

Answer: (b) 1 and 3 only

Explanation:

Statement 1 is correct: Hemagglutinin (HA) and Neuraminidase (NA) are the two primary glycoproteins found on the surface of the influenza virus. Hemagglutinin functions like a key that binds to sialic acid receptors on the surface of host cells, facilitating receptor-mediated endocytosis and viral entry. Conversely, Neuraminidase acts at the final stage of the viral lifecycle, cleaving the sialic acid bonds to liberate newly formed viral particles from the host cell so they can infect adjacent tissues.  

Statement 2 is incorrect: The process described in this statement refers to antigenic shift, not antigenic drift. Antigenic shift is a major, abrupt change resulting from genetic reassortment—often occurring when human and animal influenza viruses simultaneously infect a single host, giving rise to novel strains capable of causing global pandemics. In contrast, antigenic drift involves small, gradual point mutations within the viral genes over time, which slightly modify its surface antigens and lead to seasonal epidemics. 

Statement 3 is correct: Oseltamivir (commercially known as Tamiflu) is an approved antiviral prescription medication. It functions specifically as a neuraminidase inhibitor, binding to the active site of the neuraminidase enzyme to trap newly synthesized virions on the surface of already infected host cells, effectively stopping further spread.